$EBS $JNJ Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson &amp; Johnson’s Lead COVID-19 Vaccine Candidate  

Emergent will provide contract development and manufacturing services beginning in 2021

https://t.co/xInegdPoBJ